We are live on ! Find out more

455 hedge funds and large institutions have $3.23B invested in Chemours in 2023 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 109 increasing their positions, 166 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.87% more ownership

Funds ownership: 76.95%77.83% (+0.87%)

4% less funds holding

Funds holding: 476455 (-21)

17% less call options, than puts

Call options by funds: $57.3M | Put options by funds: $69.1M

24% less capital invested

Capital invested by funds: $4.23B → $3.23B (-$996M)

24% less first-time investments, than exits

New positions opened: 50 | Existing positions closed: 66

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

34% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 166

Holders
455
Holders Change
-21
Holders Change %
-4.41%
% of All Funds
7.22%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
50
Increased
109
Reduced
166
Closed
66
Calls
$57.3M
Puts
$69.1M
Net Calls
-$11.7M
Net Calls Change
-$20.8M

CC Hedge Fund Activity: Q3 2023 in Review

455 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q3 2023, worth a combined $3.23B — down 24% from $4.23B a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of CC and 50 opened new positions — a net loss of 16 holders — while 166 trimmed existing stakes and 109 added.

The largest buyer was Deutsche Bank, adding an estimated $59.1M. The largest seller was Fidelity Investments, cutting an estimated $50.8M.

  • 455 institutional investors held Chemours (CC) as of Q3 2023, down from 476 in Q2 2023.
  • Funds reported $3.23B of Chemours stock for Q3 2023, down 24% quarter-over-quarter.
  • 50 funds opened new Chemours positions in Q3 2023 and 66 closed out, a net change of -16 holders.
  • The largest Chemours buyer in Q3 2023 was Deutsche Bank, an estimated $59.1M added.
  • The largest Chemours seller in Q3 2023 was Fidelity Investments, an estimated $50.8M sold.

Based on aggregated 13F filings for Q3 2023.